Mastery EAQ Ch. 10

A  Pain relief is best obtained by administering analgesics around the clock.

B  Analgesics should be administered as needed to minimize adverse effects.

C  Patients should request analgesics when the pain level reaches a 3 on a scale of 1 to 10.

D  Narcotic analgesics should not be used for more than 24 hours.

A  Hallucinations, Slow pupil reaction, Altered consciousness

B  Slow pupil reaction, Excess urination, Change in sputum color

C  Altered consciousness, Excess urination, Change in sputum color

D  Excess urination, Hallucinations, Change in sputum color

A  Placed on an area after cleaning it

B  Placed on a hairy area

C  Placed on the same place as the old patch

D  Placed on a new area, with the old patch still in place

A  Distract the patient for 2 hours by using alternative methods, such as music therapy.

B  Administer the scheduled opioid dose early.

C  Ask the patient to bear the pain until the next scheduled opioid dose.

D  Administer a short-acting opioid and follow the regular opioid schedule for the next dose.

A  “Increase the dose of morphine if there is no relief of pain.”
“Take acetaminophen with the morphine.”

B  “Increase the dose of morphine if there is no relief of pain.”
“Rest before taking the medication.”

C  “Rest before taking the medication.”
“Take acetaminophen with the morphine.”

D  “Drink at least 3 liters of fluid a day.”
“Take an over-the-counter stool softener daily.”

A  Administer naloxone.

B  Call the respiratory team stat.

C  Assess arterial blood gases.

D  Prepare for intubation.

A  Diarrhea

B  Hyperactive bowel sounds

C  Sedation

D  Insomnia

A  “Do not crush the medication.”
“Swallow the medication whole.”
“Do not dissolve the medication in water.”

B  “Take the medication frequently.”
“Swallow the medication whole.”
“Increase the dose if you experience no pain relief.”

C  “Do not dissolve the medication in water.”
“Take the medication frequently.”
“Increase the dose if you experience no pain relief.”

D  “Take the medication frequently.”
“Increase the dose if you experience no pain relief.”
“Do not crush the medication.”

A  Asthma

B  Diarrhea

C  Cancer

D  Anorexia

A  Assess the patient’s neurologic status.

B  Assess blood gases.

C  Administer a narcotic antagonist.

D  Reassess the patient in an hour.

A  Serum bilirubin 3.2 mg/dL

B  Random blood glucose 140 mg/dL

C  Hemoglobin 11.2 g/dL

D  Serum creatinine 0.8 mg/dL

A  Administer 1 mg of morphine and notify the primary health care provider.

B  Hold the drug, record the assessment, and reassess the patient in 1 hour.

C  Consult the primary health care provider and obtain another drug prescription.

D  Administer another 1 mg of morphine and reevaluate the pain scale in 15 minutes.

A  Acetylcysteine

B  Protamine sulfate

C  Methylprednisolone

D  Naloxone

A  Inform the primary health care provider.

B  Administer an opioid antagonist.

C  Withhold the scheduled opioid dose.

D  Administer the scheduled opioid dose.

A  “I can understand your fears, but there is no risk of paralysis from epidural analgesia.”

B  “If you don’t turn, cough, and breathe deeply, you may get pneumonia or other complications.”

C  “There’s no needle. It’s a thin plastic tube in the protective covering of your spinal cord.”

D  “Tell me more about your understanding of how epidural analgesia relieves your pain.”

A  Nalbuphine

B  Acetylcysteine

C  Naloxone

D  Naltrexone hydrochloride

A  Within a half hour

B  In 8 hours

C  Within 2 hours

D  In 4 hours

A  Respiratory rate 28 breaths/min

B  Pinpoint pupils

C  Heart rate 110 beats/min

D  Blood in urine

A  Administer flumazenil.

B  Prepare intravenous naloxone.

C  Initiate resuscitative measures.

D  Assess the patients’ responsiveness.

A  Cough reflex

B  Chemoreceptor trigger zone

C  Respiratory rate

D  Circulation

A  No bowel movement in 72 hours

B  Vague feeling of anxiety

C  Respiratory rate 12 breaths/min

D  Heart rate 90 beats/min

A  Administer an amphetamine.

B  Assess the patient’s electrocardiogram (ECG).

C  Assess the patient for pain.

D  Administer naltrexone hydrochloride.

A  Questions regarding the date of the last flu vaccine

B  Questions regarding past history of drug and alcohol use

C  Assessment of culture reports

D  Assessment of chronic diseases causing pain

A  Nausea, Joint pain, Muscle stiffness

B  Skin rashes, Blurred vision, Nausea

C  Joint pain, Skin rashes, Blurred vision

D  Skin rashes, Muscle stiffness, Blurred vision

A  “Keep new and used patches away from children.”

B  “Apply heat over the patch to increase absorption.”

C  “Dispose of patches by melting them with a flame.”

D  “Store the patches in the bathroom medicine cabinet.”

A  Binds in place of the agonist and causes no response

B  Binds instead of the agonist and causes analgesia

C  Binds and causes a response opposite to that of an agonist

D  Binds and causes less pain response than an agonist

A  125 mg

B  107 mg

C  150 mg

D  100 mg

A  Superficial pain

B  Somatic pain

C  Visceral pain

D  Deep pain

A  Diarrhea

B  Dizziness

C  Miosis

D  Constipation

A  “This medication helps open up your airways.”

B  “This medication is used as a cough suppressant.”

C  “This medication will help you get rid of mucous.”

D  “This medication will help your immune system.”

A  “The disability benefit of your insurance plan will help pay your bills.”

B  “Everything will be fine. You will be back to work in about 6 weeks.”

C  “Tell me more about your fears.”

D  “Your pain is well controlled now. Why are you so worried?”

A  Blood pressure

B  Heart rate

C  Mental status

D  Respiratory rate

A  Mucosal irritation

B  Electrolyte imbalance

C  Constipation

D  Crystalluria

A  Blurred vision, Vomiting, Decreased hearing

B  Blurred vision, Decreased hearing, Elevated liver enzymes

C  Nausea, Vomiting, Elevated liver enzymes

D  Nausea, Blurred vision, Decreased hearing

A  Add a second patch.

B  Call the primary health care provider.

C  Change the patch.

D  Administer naloxone.

A  0.5 mg

B  0.8 mg

C  0.4 mg

D  1 mg

A  Aspartate transaminase (AST) and alanine transaminase (ALT) levels

B  Platelet count

C  Neutrophil count

D  Blood urea nitrogen (BUN) and creatinine levels

A  Anemia

B  Severe liver disease

C  Joint pain

D  Asthma

A  Somatic pain

B  Visceral pain

C  Deep pain

D  Superficial pain

A  Lower back pain related to lumbar strain

B  Pain after abdominal surgery

C  Severe pain resulting from cancer metastasis

D  Acute migraine

A  Hydromorphone

B  Codeine sulfate

C  Fentanyl

D  Meperidine

A  Sudden onset

B  Sharp

C  Persistent

D  Sympathetic nervous system response

A  Naloxone

B  Flumazenil

C  Acetylcysteine

D  Methylprednisolone

A  To diminish feelings of anxiety

B  To induce a state of unconsciousness

C  To relieve acute and chronic pain

D  To treat ischemic pain

A  Neuropathic pain

B  Vascular pain

C  Referred pain

D  Phantom pain